Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Myelogenous”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)UnknownNCT04353479
What this trial is testing

Combined PD1 Inhibitor and Decitabine in Elderly Patients With Relapse and Refractory Acute Myeloid Leukemia

Who this might be right for
Acute Myeloid Leukemia
Shanghai Jiao Tong University School of Medicine 29
Testing effectiveness (Phase 2)Active Not RecruitingNCT04233346
What this trial is testing

The Study for CML Who Failed Prior TKIs or With T315I Mutation or Ph+ ALL Who Failed Prior TKIs or With T315I Mutation

Who this might be right for
Chronic Myeloid LeukemiaAcute Lymphoblastic Leukemia
Otsuka Beijing Research Institute 93
Testing effectiveness (Phase 2)Looking for participantsNCT06138990
What this trial is testing

Pharmacoscopy-guided Clinical Standard-of-care in r/r AML

Who this might be right for
AML, Adult
ETH Zurich 88
Not applicableLooking for participantsNCT05682924
What this trial is testing

Condition Vasoregulation Function Endothelium in Patients With CML Getting TKI II Generation Bosutinib

Who this might be right for
Chronic Myeloid Leukaemia
Samara State Medical University 105
Testing effectiveness (Phase 2)Study completedNCT01883362
What this trial is testing

Standard of Care +/- Midostaurin to Prevent Relapse Post Stem Cell Transplant in Patients With FLT3-ITD Mutated AML

Who this might be right for
Acute Myeloid Leukemia
Novartis Pharmaceuticals 60
Early research (Phase 1)Looking for participantsNCT06737523
What this trial is testing

Chiglitazar Sodium Combined With Venetoclax and Azacitidine (CVA) for the Treatment of R/R AML

Who this might be right for
Acute Myeloid LeukemiaRelapseRefractory AML
The First Affiliated Hospital of Xiamen University 30
Very early researchUnknownNCT03795779
What this trial is testing

CLL1-CD33 cCAR in Patients With Relapsed and/or Refractory, High Risk Hematologic Malignancies

Who this might be right for
Hematologic MalignancyAcute Myeloid LeukemiaMyelodysplastic Syndromes+2 more
iCell Gene Therapeutics 20
Not applicableStudy completedNCT04326023
What this trial is testing

Myelodysplastic Syndrome and Acute Myeloid Leukemia Related to PARP Inhibitors (MyeloRIB)

Who this might be right for
Cancer
University Hospital, Caen 178
Testing effectiveness (Phase 2)Looking for participantsNCT07148180
What this trial is testing

A Multi-Site Break Through Cancer Trial: Targeting Measurable Residual Disease in Patients With Acute Myeloid Leukemia: A Phase 1/2 Study of Tagraxofusp, Azacitidine, and Venetoclax

Who this might be right for
Acute Myeloid Leukaemia (AML)LeukemiaBlood Cancer+1 more
Jacqueline Garcia, MD 31
Large-scale testing (Phase 3)Ended earlyNCT01339910
What this trial is testing

Reduced Intensity Regimen vs Myeloablative Regimen for Myeloid Leukemia or Myelodysplastic Syndrome (BMT CTN 0901)

Who this might be right for
Leukemia, Myelocytic, Acute
Medical College of Wisconsin 272
Early research (Phase 1)UnknownNCT04365179
What this trial is testing

Study of NEROFE, a Novel Hormone-Peptide in Adult Patients With Advanced MDS and AML

Who this might be right for
Advanced MDSAML
Immune System Key Ltd 18
Testing effectiveness (Phase 2)Active Not RecruitingNCT03744390
What this trial is testing

IDH2 (AG 221) Inhibitor in Patients With IDH2 Mutated Myelodysplastic Syndrome

Who this might be right for
Myelodysplastic SyndromesLeukemia Acute Myeloid
Groupe Francophone des Myelodysplasies 68
Large-scale testing (Phase 3)UnknownNCT00327262
What this trial is testing

Comparing Imatinib Standard Dose With Imatinib High Dose Induction in Pretreated Chronic Myeloid Leukemia (CML) Patients in Chronic Phase

Who this might be right for
Chronic Myeloid Leukemia
Central European Leukemia Study Group 240
Early research (Phase 1)Looking for participantsNCT03630991
What this trial is testing

Edetate Calcium Disodium or Succimer in Treating Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome Undergoing Chemotherapy

Who this might be right for
Acute Myeloid LeukemiaAcute Myeloid Leukemia Arising From Previous Myelodysplastic SyndromeBlast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive+15 more
M.D. Anderson Cancer Center 58
Early research (Phase 1)Study completedNCT02892318
What this trial is testing

A Study Evaluating the Safety and Pharmacology of Atezolizumab Administered in Combination With Immunomodulatory Agents in Participants With Acute Myeloid Leukemia (AML)

Who this might be right for
Acute Myeloid Leukemia
Hoffmann-La Roche 40
Early research (Phase 1)Ended earlyNCT02676323
What this trial is testing

Panobinostat With Fludarabine and Cytarabine for Treatment of Children With Acute Myeloid Leukemia or Myelodysplastic Syndrome

Who this might be right for
Acute Myeloid LeukemiaMyelodysplastic Syndrome
St. Jude Children's Research Hospital 19
Early research (Phase 1)Study completedNCT00004862
What this trial is testing

Augmerosen Plus Fludarabine and Cytarabine in Treating Patients With Refractory or Relapsed Acute Myeloid Leukemia or Acute Lymphoblastic Leukemia

Who this might be right for
Leukemia
National Cancer Institute (NCI) 24
Testing effectiveness (Phase 2)Study completedNCT01238211
What this trial is testing

Combination Chemotherapy and Dasatinib in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia

Who this might be right for
Acute Myeloid LeukemiaAcute Myeloid Leukemia Arising From Previous Myelodysplastic SyndromeAdult Acute Myeloid Leukemia With Inv(16)(p13.1q22); CBFB-MYH11+5 more
National Cancer Institute (NCI) 61
Post-approval studies (Phase 4)Study completedNCT01660906
What this trial is testing

Phase IV, Open-label, Multicenter Study of Dasatinib in Chronic-Phase Chronic Myeloid Leukemia (CP-CML) Patients With Chronic, Low-grade Non-Hematologic Toxicity to Imatinib

Who this might be right for
Chronic Phase Chronic Myeloid Leukemia
Bristol-Myers Squibb 39
Early research (Phase 1)Study completedNCT00087204
What this trial is testing

Rebeccamycin Analog in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia, Myelodysplastic Syndrome, Acute Lymphoblastic Leukemia, or Chronic Myelogenous Leukemia

Who this might be right for
Adult Acute Myeloid Leukemia With 11q23 (MLL) AbnormalitiesAdult Acute Myeloid Leukemia With Inv(16)(p13;q22)Adult Acute Myeloid Leukemia With t(15;17)(q22;q12)+13 more
National Cancer Institute (NCI) 40
Next Page